Jonathan Regenold

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis”.

Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis

Eye(2022)10.1038/s41433-022-02315-9

N/A

0DataRank · unranked

13 citations

Günay Uludağ, Wataru Matsumiya, Jonathan Regenold, Christopher Or, Azadeh Mobasserian +7 more

Reply

Retina(2024)10.1097/iae.0000000000004134

N/A

0DataRank · unranked

0 citations

Irmak Karaca, Brandon Pham, Amir Akhavanrezayat, Günay Uludağ, Çigdem Yaşar +9 more